John P. Neoptolemos

Development of Multiple Reaction Monitoring techniques for the quantification of biomarkers of pancreatic cancer

John F. Timms, Elliott, Claire Jenkinson, 2011 .

The Value of Source Data Verification in a Cancer Clinical Trial

Catrin Tudur Smith, John P. Neoptolemos, Janet Dunn, 2012, PloS one.

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

Krzysztof Jamroziak, Ugo Boggi, Pavel Soucek, 2016, Oncotarget.

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Robert C. Green, Andrew J. Saykin, Liana G. Apostolova, 2012, Nature Genetics.

Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis

John P. Neoptolemos, J. Neoptolemos, R. Sutton, 2016, Annals of surgery.

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

John R. Mackey, Fiona Campbell, David Goldstein, 2014, Journal of the National Cancer Institute.

The pancreas : an integrated textbook of basic science, medicine, and surgery

Markus W. Büchler, John P. Neoptolemos, David C. Whitcomb, 2008 .